Timbuktu Capital Management, LLC

Position in NVS — Novartis AG

CIK 2150168 BOSTON, MA

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$62,688

New position

Shares Held

400

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#1,415

of 1,603 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Timbuktu Capital Management, LLC holds $355,072 across 3 Drug Manufacturers - General names. NVS ranks #2 (17.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,039	$263,874
2	NVS	Novartis AG This page	400	$62,688
3	PFE	Pfizer Inc	1,184	$28,510

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$62,688	400	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.